By incubating murine NIH-3 T3 cells with plasma from patients with KRAS mutated colorectal tumors followed by injection into mice, the development of tumors could subsequently be observed as well as the detection of human KRAS mutations in the mice’ plasma [29,30]. This evidence concerns the gene KRAS and colorectal neoplasm.